Your browser doesn't support javascript.
loading
Signal Transduction Regulators in Axonal Regeneration.
Hausott, Barbara; Glueckert, Rudolf; Schrott-Fischer, Anneliese; Klimaschewski, Lars.
Afiliación
  • Hausott B; Institute of Neuroanatomy, Medical University Innsbruck, 6020 Innsbruck, Austria.
  • Glueckert R; Department of Otorhinolaryngology, Medical University Innsbruck, 6020 Innsbruck, Austria.
  • Schrott-Fischer A; Department of Otorhinolaryngology, Medical University Innsbruck, 6020 Innsbruck, Austria.
  • Klimaschewski L; Institute of Neuroanatomy, Medical University Innsbruck, 6020 Innsbruck, Austria.
Cells ; 11(9)2022 05 04.
Article en En | MEDLINE | ID: mdl-35563843
ABSTRACT
Intracellular signal transduction in response to growth factor receptor activation is a fundamental process during the regeneration of the nervous system. In this context, intracellular inhibitors of neuronal growth factor signaling have become of great interest in the recent years. Among them are the prominent signal transduction regulators Sprouty (SPRY) and phosphatase and tensin homolog deleted on chromosome 10 (PTEN), which interfere with major signaling pathways such as extracellular signal-regulated kinase (ERK) or phosphoinositide 3-kinase (PI3K)/Akt in neurons and glial cells. Furthermore, SPRY and PTEN are themselves tightly regulated by ubiquitin ligases such as c-casitas b-lineage lymphoma (c-CBL) or neural precursor cell expressed developmentally down-regulated protein 4 (NEDD4) and by different microRNAs (miRs) including miR-21 and miR-222. SPRY, PTEN and their intracellular regulators play an important role in the developing and the lesioned adult central and peripheral nervous system. This review will focus on the effects of SPRY and PTEN as well as their regulators in various experimental models of axonal regeneration in vitro and in vivo. Targeting these signal transduction regulators in the nervous system holds great promise for the treatment of neurological injuries in the future.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fosfatidilinositol 3-Quinasas / MicroARNs Tipo de estudio: Prognostic_studies Idioma: En Revista: Cells Año: 2022 Tipo del documento: Article País de afiliación: Austria

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fosfatidilinositol 3-Quinasas / MicroARNs Tipo de estudio: Prognostic_studies Idioma: En Revista: Cells Año: 2022 Tipo del documento: Article País de afiliación: Austria